A clinical trial in healthy volunteers and patients with mild asthma to investigate a new medicine (AZD4604) for the treatment of asthma

Trial Identifier: D8210C00001
Sponsor: AstraZeneca
NCTID:: NCT04769869
Start Date: July 2022
Primary Completion Date: January 2023
Study Completion Date: January 2023
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
GB Belfast, GB, BT9 6AD
GB Cambridge, GB, CB2 0AU
GB Harrow, GB, HA1 3UJ
GB London, GB, SE1 1YR
GB Manchester, GB, M23 9QZ